Annual Current Liabilities
$22.82 M
+$6.38 M+38.77%
December 31, 2022
Summary
- As of February 10, 2025, RXDX annual total current liabilities is $22.82 million, with the most recent change of +$6.38 million (+38.77%) on December 31, 2022.
- During the last 3 years, RXDX annual current liabilities has fallen by -$9.06 million (-28.42%).
Performance
RXDX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
$19.34 M
-$3.48 M-15.24%
March 31, 2023
Summary
- As of February 10, 2025, RXDX quarterly total current liabilities is $19.34 million, with the most recent change of -$3.48 million (-15.24%) on March 31, 2023.
- Over the past year, RXDX quarterly current liabilities has increased by +$2.02 million (+11.64%).
Performance
RXDX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
RXDX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +38.8% | +11.6% |
| 3 y3 years | -28.4% | - |
| 5 y5 years | -28.4% | - |
RXDX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -27.9% | -18.7% | -15.0% |
| 5 y | 5-year | -28.4% | -33.1% | -18.7% | -54.6% |
| alltime | all time | -28.4% | -33.1% | -18.7% | -54.6% |
Prometheus Biosciences Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $19.34 M(-15.2%) |
| Dec 2022 | $22.82 M(+38.8%) | $22.82 M(-4.0%) |
| Sep 2022 | - | $23.78 M(+44.4%) |
| Jun 2022 | - | $16.47 M(-4.9%) |
| Mar 2022 | - | $17.32 M(+5.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $16.44 M(+7.8%) | $16.44 M(+8.9%) |
| Sep 2021 | - | $15.09 M(-14.7%) |
| Jun 2021 | - | $17.70 M(+101.4%) |
| Mar 2021 | - | $8.79 M(-42.4%) |
| Dec 2020 | $15.26 M(-52.1%) | $15.26 M |
| Dec 2019 | $31.88 M | - |
FAQ
- What is Prometheus Biosciences annual total current liabilities?
- What is the all time high annual current liabilities for Prometheus Biosciences?
- What is Prometheus Biosciences annual current liabilities year-on-year change?
- What is Prometheus Biosciences quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Prometheus Biosciences?
- What is Prometheus Biosciences quarterly current liabilities year-on-year change?
What is Prometheus Biosciences annual total current liabilities?
The current annual current liabilities of RXDX is $22.82 M
What is the all time high annual current liabilities for Prometheus Biosciences?
Prometheus Biosciences all-time high annual total current liabilities is $31.88 M
What is Prometheus Biosciences annual current liabilities year-on-year change?
Over the past year, RXDX annual total current liabilities has changed by +$6.38 M (+38.77%)
What is Prometheus Biosciences quarterly total current liabilities?
The current quarterly current liabilities of RXDX is $19.34 M
What is the all time high quarterly current liabilities for Prometheus Biosciences?
Prometheus Biosciences all-time high quarterly total current liabilities is $23.78 M
What is Prometheus Biosciences quarterly current liabilities year-on-year change?
Over the past year, RXDX quarterly total current liabilities has changed by +$2.02 M (+11.64%)